Table 2 Univariate and multivariate analysis of characteristics of patients who stopped smoking
Continued to smoke | Stopped smoking | Crude Odds Ratio (95% confidence interval) | Adjusted odds ratio (95% confidence interval) | |
|---|---|---|---|---|
Count (%) | Count (%) | |||
Smoking Cessation Group | ||||
GP | 191 (52.5) | 110 (46.4) | 0.78 (0.56,1.09) | 0.79 (0.56,1.13) |
IC | 173 (47.5) | 127 (53.6) | ||
Sociodemographic data | ||||
Age | 46.6 | 45.14 | ||
Mean (±SD) | (±12.26) | (±12.14) | 0.99 (0.98,1.00) | 0.99 (0.97,1.00) |
Gender | ||||
Male | 217 (59.6) | 133 (56.1) | ref | ref |
Female | 147 (40.4) | 104 (43.9) | 1.15(0.83,1.61) | 1.21 (0.84,1.74) |
SES Group | ||||
1–3 (low) | 36 (9.9) | 14 (5.9) | 0.70 (0.36,1.34) | 0.81 (0.41,1.58) |
4–7 (reference) | 257 (70.6) | 143 (60.3) | ref | ref |
8–10 (high) | 71 (19.5) | 80 (33.8) | 2.02 (1.39,2.96) | 2.06 (1.39,3.07) |
Presence of Chronic Diseases | ||||
Diabetes Mellitus type 2 | ||||
Yes | 40 (11.8) | 18 (8.6) | 0.70 (0.39,1.26) | |
No | 299 (88.2) | 192 (91.4) | ref | |
Essential Hypertension | ||||
Yes | 79 (23.3) | 36 (17.1) | 0.68 (0.44,1.06) | |
No | 260 (76.7) | 174 (82.9) | ref | |
Ischemic Heart Disease | ||||
Yes | 48 (14.2) | 17 (8.1) | 0.53(0.30,0.96) | 0.59 (0.31,1.12) |
No | 291 (85.8) | 193 (91.9) | ref | ref |
Chronic Obstructive Pulmonary Disease | ||||
Yes | 10 (2.9) | 13 (6.2) | 2.17 (0.93,5.04) | 2.46 (0.96,6.30) |
No | 329 (97.1) | 197 (93.8) | ref | ref |
History of malignancy | ||||
Yes | 17 (5.0) | 9 (4.3) | 0.84 (0.37,1.93) | |
No | 321 (95.0) | 201 (95.7) | ref | |
Smoking related variables | ||||
Cigarettes per day | ||||
Mean (±SD) | 21.0 (±9.6) | 19.4 (±10.3) | 0.98 (0.97,1.00) | 0.98 (0.97,1.00) |
Duration of Smoking, years | 25.1 (±11.8) | 23.1 (±12.2) | 0.99 (0.97,1.00) | |
Duration of consumption of varenicline in months | 2.04 (±1.2) | 2.55 (±1.7) | 1.27 (1.14,1.43) | 1.30 (1.15,1.47) |